Mark A. Goldberg, M.D.

Dr. Goldberg is an Operating Partner of Arsenal for the healthcare team. Prior to joining Arsenal in 2026, he was CEO at Allucent, a global drug development services firm focused on the needs of biotechnology companies, where he remains Chairman. He also served as Executive Chairman of THREAD, a clinical research technology and consulting services company. Earlier, Dr. Goldberg spent 21 years at PAREXEL International, where he held multiple leadership roles including President and Chief Operating Officer. In that capacity, he oversaw all revenue generating business segments including Clinical Research Services, PAREXEL Informatics, and PAREXEL Consulting.